October 2, 2024 Sophia Vida
Breaking News

Oncocyte Signs Leading Transplant Centers in US and Germany

GraftAssure™ research assay adopted by two research hospitals that are top-five-in-country by organ transplant volume Company clears first stage gate in clinical product development process and has submitted a Q-Sub to the FDA IRVINE, Calif., Oct. 02, 2024 – PRISM MediaWire – Oncocyte Corporation (Nasdaq: OCX) (“Oncocyte” or the “Company”), a diagnostics technology company, today … Continue reading “Oncocyte Signs Leading Transplant Centers in US and Germany”